|
04 Jan 2011 |
Alnylam Demonstrates RNAi in Man with Systemically Delivered RNAi Therapeutics
|
|
04 Jan 2011 |
Isis Initiates Broad Phase 2 Program of ISIS-EIF4ERx in Cancer
|
|
03 Jan 2011 |
Advanced Cell Technology Receives FDA Clearance For Clinical Trials Using Embryonic Stem Cells to Treat Age-Related Macular Degeneration
|
|
27 Dec 2010 |
AVI BioPharma Provides Update on Duchenne Muscular Dystrophy Program
|
|
22 Dec 2010 |
Tekmira Initiates TKM-PLK1 Phase 1 Human Clinical Trial
|
|
21 Dec 2010 |
Amorcyte Stem Cell Therapy Demonstrates Clinically Significant Reperfusion in Severe Heart Attack Patients
|
|
21 Dec 2010 |
Isis Initiates Phase 1 Clinical Trial of ISIS-APOCIIIRx to Treat Hypertriglyceridemia
|
|
20 Dec 2010 |
Idera Pharmaceuticals Announces Preliminary Data from Phase 1 Clinical Trial of IMO-2125 in Treatment-Naïve Genotype 1 HCV Patients
|
|
20 Dec 2010 |
Fibrocell Science, Inc. Submits Complete Response to FDA Regarding Azficel-T
|
